Literature DB >> 22590697

Canadian Digestive Health Foundation Public Impact Series 3: irritable bowel syndrome in Canada. Incidence, prevalence, and direct and indirect economic impact.

Richard N Fedorak1, Stephen J Vanner, William G Paterson, Ron J Bridges.   

Abstract

The Canadian Digestive Health Foundation initiated a scientific program to assess the incidence, prevalence, mortality and economic impact of digestive disorders across Canada in 2009. The current article presents the updated findings from the study concerning irritable bowel syndrome.

Entities:  

Mesh：

Year:  2012        PMID： 22590697      PMCID： PMC3352839          DOI： 10.1155/2012/861478

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN： 0835-7900            Impact factor:   3.522


  44 in total

Review 1.  Abdominal pain in Irritable Bowel Syndrome: a review of putative psychological, neural and neuro-immune mechanisms.

Authors:  Sigrid Elsenbruch
Journal:  Brain Behav Immun       Date:  2010-11-20       Impact factor: 7.217

2.  The incidence of abdominal and pelvic surgery among patients with irritable bowel syndrome.

Authors:  J Alexander Cole; Jason M Yeaw; Jennifer A Cutone; Braden Kuo; Zhiping Huang; David L Earnest; Alexander M Walker
Journal:  Dig Dis Sci       Date:  2005-12       Impact factor: 3.199

3.  Incidence and epidemiology of irritable bowel syndrome after a large waterborne outbreak of bacterial dysentery.

Authors:  John K Marshall; Marroon Thabane; Amit X Garg; William F Clark; Marina Salvadori; Stephen M Collins
Journal:  Gastroenterology       Date:  2006-08       Impact factor: 22.682

4.  Irritable bowel syndrome and health-related quality of life: a population-based study in Calgary, Alberta.

Authors:  Feng Xiao Li; Scott B Patten; Robert J Hilsden; Lloyd R Sutherland
Journal:  Can J Gastroenterol       Date:  2003-04       Impact factor: 3.522

5.  Association of symptoms with gastrointestinal microbiota in irritable bowel syndrome.

Authors:  Erja Malinen; Lotta Krogius-Kurikka; Anna Lyra; Janne Nikkilä; Anne Jääskeläinen; Teemu Rinttilä; Terttu Vilpponen-Salmela; Atte Johannes von Wright; Airi Palva
Journal:  World J Gastroenterol       Date:  2010-09-28       Impact factor: 5.742

Review 6.  Costs of irritable bowel syndrome in the UK and US.

Authors:  Stefanie Maxion-Bergemann; Frank Thielecke; Florian Abel; Rito Bergemann
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

7.  Gender distribution in irritable bowel syndrome is proportional to the severity of constipation relative to diarrhea.

Authors:  Jeremy Herman; Venkata Pokkunuri; Lena Braham; Mark Pimentel
Journal:  Gend Med       Date:  2010-06

Review 8.  Irritable bowel syndrome: epidemiology, diagnosis and treatment: an update for health-care practitioners.

Authors:  Oliver Grundmann; Saunjoo L Yoon
Journal:  J Gastroenterol Hepatol       Date:  2010-01-13       Impact factor: 4.029

9.  Functional gastrointestinal disorders in children: an Italian prospective survey.

Authors:  Erasmo Miele; Domenico Simeone; Antonio Marino; Luigi Greco; Renata Auricchio; Steven J Novek; Annamaria Staiano
Journal:  Pediatrics       Date:  2004-07       Impact factor: 7.124

10.  Irritable bowel syndrome in the general population.

Authors:  R Jones; S Lydeard
Journal:  BMJ       Date:  1992-01-11
View more
  6 in total

1.  Symptoms of Functional Intestinal Disorders Are Common in Patients with Celiac Disease Following Transition to a Gluten-Free Diet.

Authors:  Jocelyn A Silvester; Lesley A Graff; Lisa Rigaux; Charles N Bernstein; Daniel A Leffler; Ciarán P Kelly; John R Walker; Donald R Duerksen
Journal:  Dig Dis Sci       Date:  2017-07-07       Impact factor: 3.199

2.  Meeting the Motility Educational Requirements of the Gastroenterology Trainee in the 21st Century.

Authors:  Adriana Lazarescu; Christopher N Andrews; Louis W C Liu; David Reed; William G Paterson; Stephen J Vanner; Daniel C Sadowski
Journal:  J Can Assoc Gastroenterol       Date:  2019-06-05

3.  Dietary Patterns in Runners with Gastrointestinal Disorders.

Authors:  Kelly Anne Erdman; Kim Wagner Jones; Robyn F Madden; Nancy Gammack; Jill A Parnell
Journal:  Nutrients       Date:  2021-01-29       Impact factor: 5.717

4.  Dietary gluten avoidance in Canada: a cross-sectional study using survey data.

Authors:  Adriana Mudryj; Anne Waugh; Joyce Slater; Donald R Duerksen; Charles N Bernstein; Natalie D Riediger
Journal:  CMAJ Open       Date:  2021-04-01

5.  Tang-Ping-San Decoction Remodel Intestinal Flora and Barrier to Ameliorate Type 2 Diabetes Mellitus in Rodent Model.

Authors:  Wen Yin; Si-Qi Zhang; Wen-Lin Pang; Xiao-Jiao Chen; Jing Wen; Jiong Hou; Cui Wang; Li-Yun Song; Zhen-Ming Qiu; Peng-Tao Liang; Jia-Li Yuan; Zhong-Shan Yang; Yao Bian
Journal:  Diabetes Metab Syndr Obes       Date:  2022-08-20       Impact factor: 3.249

6.  Effect of the probiotic strain Bifidobacterium animalis subsp. lactis, BB-12®, on defecation frequency in healthy subjects with low defecation frequency and abdominal discomfort: a randomised, double-blind, placebo-controlled, parallel-group trial.

Authors:  Dorte Eskesen; Lillian Jespersen; Birgit Michelsen; Peter J Whorwell; Stefan Müller-Lissner; Cathrine M Morberg
Journal:  Br J Nutr       Date:  2015-09-18       Impact factor: 3.718
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.